Three-Dimensional Prostate Mapping Biopsy Has a Potentially Significant Impact on Prostate Cancer Management
- 10 September 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (26), 4321-4326
- https://doi.org/10.1200/jco.2008.20.3497
Abstract
Purpose To compare a new staging, three-dimensional prostate mapping biopsy (3D-PMB) method with traditional transrectal ultrasound (TRUS) biopsy and assess its possible impact on patient management. Patients and Methods One hundred eighty patients with unilateral cancer on TRUS biopsy, who were considering conservative management, underwent restaging with 3D-PMB. The 3D-PMB was carried out transperineally using a brachytherapy grid under TRUS guidance. Biopsies were taken every 5 mm throughout the volume of the prostate, and labeling of the specimen coordinates allowed accurate reconstruction of the location and extent of a patient's cancer. Results 3D-PMB obtained a median of 50 cores (standard deviation, ± 20.61). One hundred ten patients (61.1%) were positive bilaterally, and 41 patients (22.7%) had Gleason scores increased to 7 or higher. Thirty-six patients had negative results on 3D-PMB. Complications of 3D-PMB were self-limited and included 14 patients (7.7%) who required short-term indwelling catheter drainage and two patients with hematuria, one of whom required overnight bladder irrigation. Conclusion 3D-PMB is a transperineal biopsy that can be safely used to accurately stage prostate cancer patients. At the present time, when patient management is increasingly based on the extent and characteristics of prostate cancer, 3D-PMB could have a profound effect on patient management.Keywords
This publication has 13 references indexed in Scilit:
- What is low-risk prostate cancer and what is its natural history?World Journal of Urology, 2008
- Peripheral Zone Prostate Cancer: Accuracy of Different Interpretative Approaches with MR and MR Spectroscopic ImagingRadiology, 2008
- Appropriate Patient Selection in the Focal Treatment of Prostate Cancer: The Role of Transperineal 3-Dimensional Pathologic Mapping of the Prostate—A 4-Year ExperienceUrology, 2007
- Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and ModalitiesJournal of Urology, 2007
- Interstitial Low Dose Rate Brachytherapy for Prostate Cancer — A Focus on Intermediate- and High-risk DiseaseClinical Oncology, 2006
- Prostate Saturation Biopsy in the Reevaluation of Microfocal Prostate CancerJournal of Urology, 2006
- Clinical staging of prostate cancer: a computer‐simulated study of transperineal prostate biopsyBJU International, 2005
- Utility of saturation biopsy to predict insignificant cancer at radical prostatectomyUrology, 2005
- Living With Untreated Localized Prostate CancerCancer Nursing, 2003
- Uncertainty and Quality of Life of Older Men Who Undergo Watchful Waiting for Prostate CancerOncology Nursing Forum, 2003